With Sean Griffin, Lucinda Low, Shannon MacMichael
On October 3, 2011, SciClone Pharmaceutical, Inc. ("SciClone"), a California specialty pharmaceutical company with substantial commercial business in China, entered into a stipulation of settlement in connection with several consolidated derivative lawsuits pending against certain members of its staff of current and former directors and officers.